JP2025501746A5 - - Google Patents
Info
- Publication number
- JP2025501746A5 JP2025501746A5 JP2024537865A JP2024537865A JP2025501746A5 JP 2025501746 A5 JP2025501746 A5 JP 2025501746A5 JP 2024537865 A JP2024537865 A JP 2024537865A JP 2024537865 A JP2024537865 A JP 2024537865A JP 2025501746 A5 JP2025501746 A5 JP 2025501746A5
- Authority
- JP
- Japan
- Prior art keywords
- fragment
- pharmaceutical product
- product according
- aat
- inhalation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21216836 | 2021-12-22 | ||
| EP21216836.3 | 2021-12-22 | ||
| EP22166483.2 | 2022-04-04 | ||
| EP22166483 | 2022-04-04 | ||
| PCT/EP2022/087461 WO2023118424A1 (en) | 2021-12-22 | 2022-12-22 | Alpha-1 antitrypsin produced from yeast for use in the treatment of viral infections |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025501746A JP2025501746A (ja) | 2025-01-23 |
| JP2025501746A5 true JP2025501746A5 (https=) | 2025-12-08 |
Family
ID=84980906
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024537865A Pending JP2025501746A (ja) | 2021-12-22 | 2022-12-22 | ウイルス感染症の治療における使用のための酵母から産生されたアルファ－１アンチトリプシン |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250057927A1 (https=) |
| EP (1) | EP4453233A1 (https=) |
| JP (1) | JP2025501746A (https=) |
| AU (1) | AU2022422304A1 (https=) |
| CA (1) | CA3241852A1 (https=) |
| IL (1) | IL313247A (https=) |
| TW (1) | TW202334430A (https=) |
| WO (1) | WO2023118424A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4480960A1 (en) * | 2023-06-22 | 2024-12-25 | AATEC Medical GmbH | A recombinant human alpha-1 antitrypsin glycoprotein |
| EP4730999A1 (en) * | 2023-06-22 | 2026-04-29 | AATEC Medical GmbH | Recombinant aat from yeast to treat transplants |
| CN121752288A (zh) * | 2023-06-22 | 2026-03-27 | 阿泰克医疗有限公司 | 重组人α-1抗胰蛋白酶糖蛋白 |
| WO2024261179A1 (en) * | 2023-06-22 | 2024-12-26 | Aatec Medical Gmbh | Recombinant aat from yeast to treat bacterial respiratory infections |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4713249A (en) | 1981-11-12 | 1987-12-15 | Schroeder Ulf | Crystallized carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof |
| US5266333A (en) | 1985-03-06 | 1993-11-30 | American Cyanamid Company | Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration of growth hormone |
| US5417982A (en) | 1994-02-17 | 1995-05-23 | Modi; Pankaj | Controlled release of drugs or hormones in biodegradable polymer microspheres |
| WO2021191900A1 (en) | 2020-03-26 | 2021-09-30 | Kamada Ltd. | Methods for treating infectious diseases caused by coronavirus |
-
2022
- 2022-12-22 TW TW111149485A patent/TW202334430A/zh unknown
- 2022-12-22 EP EP22843749.7A patent/EP4453233A1/en active Pending
- 2022-12-22 AU AU2022422304A patent/AU2022422304A1/en active Pending
- 2022-12-22 US US18/723,224 patent/US20250057927A1/en active Pending
- 2022-12-22 JP JP2024537865A patent/JP2025501746A/ja active Pending
- 2022-12-22 IL IL313247A patent/IL313247A/en unknown
- 2022-12-22 CA CA3241852A patent/CA3241852A1/en active Pending
- 2022-12-22 WO PCT/EP2022/087461 patent/WO2023118424A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025501746A5 (https=) | ||
| Blok et al. | Variation in the membrane-insertion and" stalk" sequences in eight subtypes of influenza type A virus neuraminidase | |
| JP2008522617A5 (https=) | ||
| JPS60226821A (ja) | 化学修飾リンホカインおよびその製造法 | |
| US20250057927A1 (en) | Alpha-1 antitrypsin produced from yeast for use in the treatment of viral infections | |
| US8852577B2 (en) | Recombinant proteins of Parapoxvirus ovis and pharmaceutical compositions therefrom | |
| JPH08505405A (ja) | ウィルスのエアロゾールの調製方法 | |
| JP2023536570A5 (https=) | ||
| CN114533706B (zh) | 一种用于防治呼吸道疾病的雾化吸入制剂及其应用 | |
| CN101137391B (zh) | 重组高效复合干扰素的用途 | |
| WO2023036191A1 (zh) | 新型冠状病毒SARS-CoV-2的Delta变异株疫苗与应用 | |
| JPH031320B2 (https=) | ||
| US9421243B2 (en) | Therapy for influenza like illness | |
| JP5830032B2 (ja) | インターフェロンアルファ５を生産する方法 | |
| EP1701973B1 (en) | Glutathione derivatives and their uses for the treatment of viral diseases | |
| CN109467597B (zh) | 一种新型干扰素及其制备方法、组合物和用途 | |
| EP2647645A1 (en) | Recombinant proteins of Parapoxvirus ovis and pharmaceutical compositions therefrom | |
| JPH029600B2 (https=) | ||
| KR20080071116A (ko) | 기도에 영향을 미치는 염증 질환에 있어서 활성화 단백질ｃ의 기도 투여법 | |
| EP4480960A1 (en) | A recombinant human alpha-1 antitrypsin glycoprotein | |
| CN118434880A (zh) | 由酵母生产的α-1抗胰蛋白酶用于治疗病毒感染的用途 | |
| WO2004096852A1 (fr) | Interferon$g(v) humain recombinant, son procede d'expression et ses utilisations | |
| JP2023553117A5 (https=) | ||
| CN121517529A (zh) | 一种微肽cim53及其编码基因和应用 | |
| WO2023081660A1 (en) | Das181 variant compositions |